Stocktoria
Core Laboratories Inc. /DE/ CLB
Core Laboratories Inc. /DE/ (CLB) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.37% (safety: safe). FY2025 revenue was $526.5M at a 5.6% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.54 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Mining & Extraction · percentile among 189 companies
Percentile vs other Mining & Extraction companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.186 |
| Retained earnings / assets | 0.296 |
| EBIT / assets | 0.097 |
| Equity / liabilities | 0.873 |
Sector peers · similar-size Mining & Extraction companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CLB | Core Laboratories Inc. /DE/ | 6/9 | 3.75 | 17.1 | +0.5% |
| WBI | WaterBridge Infrastructure LLC | 2/9 | 1.31 | — | +66.2% |
| RNGR | Ranger Energy Services, Inc. | 4/9 | 4.08 | 30.4 | -4.2% |
| NINE | Nine Energy Service, Inc. | 2/9 | -7.54 | — | +1.4% |
| KLXE | KLX Energy Services Holdings, Inc. | 3/9 | -6.46 | — | -10.2% |
| NCSM | NCS Multistage Holdings, Inc. | 4/9 | 3.48 | 4.9 | +13% |
| NGS | NATURAL GAS SERVICES GROUP INC | 3/9 | 2.65 | 27.8 | +9.9% |
All Mining & Extraction companies →
About Core Laboratories Inc. /DE/
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
FAQ
Is CLB financially healthy?
Core Laboratories Inc. /DE/'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does CLB pay a dividend, and is it safe?
Yes. Core Laboratories Inc. /DE/ pays a dividend yielding about 0.37% with a 6.3% payout ratio, rated “safe” for safety.
How profitable is CLB?
In FY2025, Core Laboratories Inc. /DE/ had a net margin of 5.6% and a return on equity of 10.9%.
Is CLB overvalued or undervalued?
Core Laboratories Inc. /DE/ trades at about 19.8× trailing earnings — below its 10-year norm (10-year range 20.5×–63.5×, median 31.0×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for CLB?
The average Wall-Street price target for Core Laboratories Inc. /DE/ is $16.33, about 31.2% above the recent price, from 3 analysts.
Is CLB a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Core Laboratories Inc. /DE/: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 17.1×, a dividend yield of 0.37%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.